LicianPro

KTTA stock

Pasithea Therapeutics Corp (KTTA) short interest & short volume · 2.5% of float short

Pasithea Therapeutics Corp official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

KTTA short interest rose 9.2% to 175K shares in the Oct 15, 2026 report (2.5% of float, 1.6 days to cover). Daily short volume averaged 39.7% of volume over the last 20 sessions, down from 46.1% the 20 sessions before, the 64th percentile of its own 20-day averages since Oct 6, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
175K
prior 160K
% of float
2.5%
float 6.9M
Days to cover
1.6
avg vol 112K
Change vs prior report
+9.2%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

KTTA short interest by FINRA report (last 6) · price is the close on the report date
Report dateShares short$ value shortChange% floatDays to coverPrice
Oct 15, 2026175K$72K+9.2%2.5%1.6$0.41
Sep 30, 2026160K$79K-40.8%2.3%1.1$0.49
Sep 15, 2026270K$135K-11.1%3.9%1.3$0.50
Aug 31, 2026304K$174K+19.6%4.4%1.4$0.57
Aug 14, 2026254K$122K+29.2%3.7%1.3$0.48
Jul 31, 2026197K$90K-19.1%2.8%1.0$0.46

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

% of float uses the current float for every report (no float was stored with older reports).

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Nov 11)
19.8%
17K of 84K
20-day average
39.7%
prior 46.1%
Percentile vs own history
64th
233 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Nov 11, 2026

Short squeeze score (model)

Price since settlement: +26.8%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

KTTA's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · KTTA overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-11-1116,55783,71519.8%
2026-11-1074,983262,24228.6%
2026-11-0926,479136,68019.4%
2026-11-0683,839294,65228.4%
2026-11-0579,162327,65524.2%
2026-11-04389,2371,392,42327.9%
2026-11-035,983,04311,336,71752.8%
2026-11-0257,725149,98038.5%
2026-10-3031,84543,66272.9%
2026-10-29109,101199,21254.8%

Healthcare peers with similar quant ratings

KTTA among 545 rated Healthcare stocks (Lician quant rating, Nov 13, 2026). How the rating works

KTTA short interest FAQ

What is KTTA's short interest?

Pasithea Therapeutics Corp (KTTA) had 175K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 2.5% of its 6.9M-share float.

How many days to cover does KTTA have?

1.6 days: 175K shares short divided by an average daily volume of 112K for the Oct 15, 2026 period.

Is KTTA short interest rising or falling?

KTTA short interest rose (+9.2%) from 160K to 175K shares in the Oct 15, 2026 report.

Is KTTA a short squeeze candidate?

Lician's squeeze watch scores KTTA 30 out of 100 (low) from the Oct 15, 2026 report: short interest % of float 3.4/40, days to cover 3.9/25, change in short interest vs prior report 2.8/15, price change since settlement date 20/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of KTTA daily volume is sold short?

39.7% on average over the last 20 sessions to Nov 11, 2026 (FINRA Reg SHO daily short volume; the 64th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was KTTA's latest FINRA short volume?

On Nov 11, 2026, cached FINRA short volume for Pasithea Therapeutics Corp (KTTA) was 16,557 shares, 19.8% of 83,715 total volume.

How many KTTA short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for Pasithea Therapeutics Corp (KTTA), from Oct 29, 2026 through Nov 11, 2026.

How did KTTA short volume percent change from the prior cached session?

Cached FINRA short volume for Pasithea Therapeutics Corp (KTTA) moved from 28.6% on Nov 10, 2026 to 19.8% on Nov 11, 2026, down 8.8 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.